ATE444761T1 - Methoden zum behandeln von demyelinisierenden krankheiten - Google Patents

Methoden zum behandeln von demyelinisierenden krankheiten

Info

Publication number
ATE444761T1
ATE444761T1 AT01968007T AT01968007T ATE444761T1 AT E444761 T1 ATE444761 T1 AT E444761T1 AT 01968007 T AT01968007 T AT 01968007T AT 01968007 T AT01968007 T AT 01968007T AT E444761 T1 ATE444761 T1 AT E444761T1
Authority
AT
Austria
Prior art keywords
subject
demyelinating disease
methods
treating
administering
Prior art date
Application number
AT01968007T
Other languages
English (en)
Inventor
Thomas Lane
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE444761T1 publication Critical patent/ATE444761T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Liquid Crystal Substances (AREA)
AT01968007T 2000-08-18 2001-08-17 Methoden zum behandeln von demyelinisierenden krankheiten ATE444761T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22639900P 2000-08-18 2000-08-18
PCT/US2001/025767 WO2002015932A1 (en) 2000-08-18 2001-08-17 Methods for treating demyelinating diseases

Publications (1)

Publication Number Publication Date
ATE444761T1 true ATE444761T1 (de) 2009-10-15

Family

ID=22848755

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01968007T ATE444761T1 (de) 2000-08-18 2001-08-17 Methoden zum behandeln von demyelinisierenden krankheiten

Country Status (7)

Country Link
EP (1) EP1317285B1 (de)
JP (1) JP4864278B2 (de)
AT (1) ATE444761T1 (de)
AU (2) AU8828601A (de)
CA (1) CA2420226C (de)
DE (1) DE60140136D1 (de)
WO (1) WO2002015932A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002316674B2 (en) * 2001-07-12 2007-09-13 The Regents Of The University Of California CXCL10 treatment of secondary tissue degeneration
WO2004045525A2 (en) 2002-11-15 2004-06-03 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
US8563476B2 (en) 2002-11-15 2013-10-22 Morehouse School Of Medicine Anti-CXCL9, anti-CXCL10, anti-CXCL11, anti-CXCL13, anti-CXCR3 and anti-CXCR5 agents for inflammatory disorders
WO2005060457A2 (en) * 2003-12-04 2005-07-07 Pdl Biopharma, Inc. Treatment of inflammatory bowel diseases with anti-ip-10 antibodies
AU2011250741B2 (en) * 2003-12-10 2014-04-03 E. R. Squibb & Sons, L.L.C. IP-10 antibodies and their uses
PL1691837T3 (pl) * 2003-12-10 2012-11-30 Squibb & Sons Llc IP-10 przeciwciała i ich zastosowanie
CA2678626A1 (en) 2007-02-28 2008-09-04 Novimmune S.A. Anti-ip-10 antibodies and methods of use thereof
CN103619880A (zh) 2011-04-29 2014-03-05 百时美施贵宝公司 Ip-10抗体剂量递增方法
WO2017095875A1 (en) 2015-11-30 2017-06-08 Bristol-Myers Squibb Company Anti human ip-10 antibodies and their uses
RU2769282C2 (ru) 2016-06-20 2022-03-30 Кимаб Лимитед Анти-PD-L1 и IL-2 цитокины
EP4338740A1 (de) 2022-09-13 2024-03-20 Johannes Gutenberg-Universität Mainz Transdermales pflaster zur förderung oder beschleunigung der myelinisierung und/oder remyelinisierung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU729415B2 (en) * 1996-07-12 2001-02-01 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6495569B1 (en) * 2001-04-19 2002-12-17 Millennium Pharmaceuticals, Inc. Imidazolidine compounds
US20030166589A1 (en) * 2001-06-05 2003-09-04 Nathan Karin Method and pharmaceutical composition for the treatment of multiple sclerosis

Also Published As

Publication number Publication date
WO2002015932A1 (en) 2002-02-28
AU2001288286B2 (en) 2007-05-10
CA2420226C (en) 2012-08-07
EP1317285A1 (de) 2003-06-11
EP1317285A4 (de) 2005-02-16
JP2004506696A (ja) 2004-03-04
EP1317285B1 (de) 2009-10-07
JP4864278B2 (ja) 2012-02-01
WO2002015932A9 (en) 2003-03-27
AU8828601A (en) 2002-03-04
CA2420226A1 (en) 2002-02-28
DE60140136D1 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
ATE444761T1 (de) Methoden zum behandeln von demyelinisierenden krankheiten
EP1390491A4 (de) Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
ATE459369T1 (de) Verfahren zur behandlung von entzündungen
ATE320803T1 (de) Verfahren zur behandlung von alzheimerschen krankheit
DK1478236T3 (da) Målrettet retrograd gentilförsel til motorneuroner
SV1998000050A (es) Metodos mejorados para procesar proteina c actividad
PT1039887E (pt) Metodos para o tratamento de neuro e nefro disturbios e de toxicidades terapeuticas usando compostos de aminotiol
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
ATE230439T1 (de) Gezielte gentherapie
BR0313792A (pt) Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
WO2004045507A3 (en) Anti-angiogenic uses of il-6 antagonists
PT975761E (pt) Interferao beta humano recombinante com solubilidade melhorada
ATE342067T1 (de) Verfahren zur behandlung von vaskulären proliferativen erkrankungen mit p27 und fusionen davon
DE60219614D1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
DE69929787D1 (de) Verfahren zur behandlung von neurologischen erkrankungen mit hilfe der bestimmung des bche genotyps
DE69530570D1 (de) Verfahren zur behandlung von stoehrungen des menschlichen oder tierischen koerpers durch verabreichung von aminosaeuren
ATE251886T1 (de) Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
ATE462717T1 (de) Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind
DE60208534D1 (de) Verwendung von antikörper gegen mag zur behandlung ischämischer schlaganfälle
ATE297211T1 (de) Verfahren und zusammensetzung zur behandlung von adenovirale augeninfektionen
WO2003006045A3 (en) Cxcl10 treatment of secondary tissue degeneration
MXPA02011162A (es) Proteina cln2 recombinante de humano y metodos para su reduccion y uso.
ATE345121T1 (de) Verwendung von konjugierter linolsäure zur behandlung der erkältung
WO2002021138A3 (de) Die m30-genfamilie und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties